Ikena Oncology, Inc. (IKNA)
NASDAQ: IKNA · Real-Time Price · USD
1.580
-0.030 (-1.86%)
Jan 8, 2025, 3:21 PM EST - Market open
Ikena Oncology Employees
Ikena Oncology had 43 employees as of December 31, 2023. The number of employees decreased by 37 or -46.25% compared to the previous year.
Employees
43
Change (1Y)
-37
Growth (1Y)
-46.25%
Revenue / Employee
$15,326
Profits / Employee
-$1,386,023
Market Cap
76.25M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 43 | -37 | -46.25% |
Dec 31, 2022 | 80 | 13 | 19.40% |
Dec 31, 2021 | 67 | 34 | 103.03% |
Dec 31, 2020 | 33 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
IKNA News
- 16 days ago - Ikena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement - GlobeNewsWire
- 2 months ago - Ikena Oncology Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 5 months ago - Ikena Oncology Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 8 months ago - UPDATE – Ikena Oncology Announces Strategic Update - GlobeNewsWire
- 8 months ago - Ikena Oncology Announces Strategic Update - GlobeNewsWire
- 8 months ago - Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update - GlobeNewsWire
- 9 months ago - Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum - GlobeNewsWire
- 10 months ago - Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire